Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

ANAB

AnaptysBio

$80.73

5.46 (7.25%)

04:55
06/19/18
06/19
04:55
06/19/18
04:55
Conference/Events
AnaptysBio management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

GILD

Gilead

$69.05

-1.16 (-1.65%)

04:55
06/19/18
06/19
04:55
06/19/18
04:55
Conference/Events
Gilead management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

Yesterday
CYTK

Cytokinetics

$9.95

0.5 (5.29%)

07:15
06/18/18
06/18
07:15
06/18/18
07:15
Recommendations
Cytokinetics analyst commentary at H.C. Wainwright »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

CYTK

Cytokinetics

$9.95

0.5 (5.29%)

06:04
06/18/18
06/18
06:04
06/18/18
06:04
Conference/Events
Cytokinetics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

CYTK

Cytokinetics

$9.95

0.5 (5.29%)

05:27
06/18/18
06/18
05:27
06/18/18
05:27
Recommendations
Cytokinetics analyst commentary at Piper Jaffray »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$9.95

0.5 (5.29%)

05:27
06/18/18
06/18
05:27
06/18/18
05:27
Hot Stocks
Cytokinetics announces data from reldesemtiv Phase 2 clinical study »

Cytokinetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Sunday
CYTK

Cytokinetics

$9.95

0.5 (5.29%)

16:15
06/17/18
06/17
16:15
06/17/18
16:15
Hot Stocks
Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA »

Cytokinetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Friday
NKTR

Nektar

$57.61

1.18 (2.09%)

15:33
06/15/18
06/15
15:33
06/15/18
15:33
Recommendations
Nektar analyst commentary at Mizuho »

Nektar's 214 still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$71.17

0.45 (0.64%)

08:41
06/15/18
06/15
08:41
06/15/18
08:41
Conference/Events
Gilead management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.